Contact Us

HOTEL NEWS

WuXi Biologics Launches EffiX™ Microbial Expression Platform to Boost Recombinant Protein and Plasmid DNA Production

Mar 5, 2025

- EffiX™ is designed to meet the industry\'s demand for a high-yield,stable,and non-lysogenic E. coli expression system. It serves as a comprehensive solution for the development and manufacturing of

Huawei Launches AI-Ready Data Storage for Carriers to Embrace AI

Mar 5, 2025

BARCELONA,Spain,March 4,2025-- At MWC 2025 Barcelona,Dr. Peter Zhou,President of Huawei Data Storage Product Line,delivered a keynote speech on AI-Ready Data Storage Accelerates Telco-to-Techco Transf

TECNO Partners with Koç University to Advance Mobile Imaging Aesthetics in Türkiye

Mar 5, 2025

BARCELONA,Spain and ISTANBUL,March 4,2025-- TECNO,an AI-driven technology brand,is teaming up with Koç University in Türkiye,a leading research university located at the intersection of E

Property for Industry (PFI) Extends Partnership with Yardi

Mar 5, 2025

Industrial specialist to centralise document management and automate processes AUCKLAND,New Zealand,March 4,2025-- Property for Industry (PFI),a specialist in the industrial sector,has extended its p

Create the AI Future: TECNO Unveils Next-Gen AI Ecosystem at MWC Barcelona 2025

Mar 5, 2025

TECNO will showcase its cutting-edge AI ecosystem,delivering practical AI solutions tailored for emerging markets. Highlights include the debut of the CAMON 40 imaging flagship smartphone,next-genera

Celltrion receives U.S. FDA approval for STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) biosimilars referencing PROLIA® and XGEVA®

Mar 5, 2025

STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of reference products PROLIA® (denosumab) and XGEVA® (denosumab) respectively[1],[2]

1 ... 47 48 49 50 51 52 53 ... 352